2024-02-15 03:09:03 ET
Summary
- Celestica's Q4 results were better than expected, but the focus should be on investor expectations rather than high-growth stocks.
- The Q1 2024 outlook for CLS is surprisingly strong, indicating a potential growth of 60% in EPS.
- The Company's valuation at 18x forward free cash flow is attractive for a business with a projected 12% CAGR in 2024.
Investment Thesis
Celestica ( CLS ) delivered Q4 results that were slightly better than I expected. But as I've stated throughout, as an inflection investor, it's much more important to understand and gauge what investors are pricing in, rather than simply picking out high-growth stocks....
Read the full article on Seeking Alpha
For further details see:
Celestica: Why I'm Buying This Stock